WIRB-Copernicus Group Acquires Vigilare International

Article

Applied Clinical Trials

WIRB Copernicus Group® announced its acquirement of Vigilare International, a provider of integrated, end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry. This new acquistion is a perfect fit for both companies as Vigilare compliments WCG's existing clinical research solutions and they plan to identify more opportunities to streamline clinical research operations.

Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.